The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Fexofenadine hydrochloride 120 mg Film-coated tablets



Chanelle Medical Unlimited CompanyPA0688/017/001

Main Information

Trade NameFexofenadine hydrochloride 120 mg Film-coated tablets
Active SubstancesFexofenadine hydrochloride
Dosage FormFilm-coated tablet
Licence HolderChanelle Medical Unlimited Company
Licence NumberPA0688/017/001

Group Information

ATC CodeR06AX Other antihistamines for systemic use
R06AX26 fexofenadine

Status

License statusAuthorised
Licence Issued14/09/2007
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back